CD80 and cancer: Our data expand on the causes of T-cell suppression as we have further identified an increase in immunosuppressive markers expressed on KEAP1-mutant cancer cells that inhibit the T-cell response (PD-L1 [45], CD80/CD86 [46,47], and CD155 [49,50]).